Allen D. Roses
Northwestern University · 504 works · 57,113 citations · h-index 94
Top works
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
- Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
- Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
- Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase
- Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
- Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
- Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment
- Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene
- Duchenne muscular dystrophy
- Pharmacogenetics and the practice of medicine
- Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
- A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex
- Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
- A 4-Mb High-Density Single Nucleotide Polymorphism-Based Map around Human APOE
- Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype
- Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases
- Apolipoprotein E Affects the Rate of Alzheimer Disease Expression: β-Amyloid Burden Is a Secondary Consequence Dependent on APOE Genotype and Duration of Disease
- Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease